Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Verve Therapeutics Inc (VERV)

Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

VERV : 6.05 (+2.02%)
Verve Therapeutics: Q2 Earnings Snapshot

Verve Therapeutics: Q2 Earnings Snapshot

VERV : 6.05 (+2.02%)
After a Serious Setback, Is Verve Therapeutics a Buy?

There are a few silver linings at play here.

VERV : 6.05 (+2.02%)
Stocks Close Lower on Fears Fed Rate Cuts Will be Delayed

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.94%. Stock indexes...

$SPX : 5,712.69 (-0.28%)
SPY : 569.81 (-0.22%)
$DOWI : 41,794.60 (-0.61%)
DIA : 418.05 (-0.56%)
$IUXX : 19,963.60 (-0.35%)
QQQ : 486.01 (-0.29%)
^BTCUSD : 67,865.18 (+1.22%)
ZNZ24 : 110-135 (+0.06%)
HUM : 255.55 (-1.98%)
CVS : 54.65 (-2.08%)
UNH : 557.77 (-1.72%)
CNC : 63.82 (+0.47%)
Stocks Fall as Bond Yields Climb on Strong US Economic News

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.51%. Stock indexes this...

$SPX : 5,712.69 (-0.28%)
SPY : 569.81 (-0.22%)
$DOWI : 41,794.60 (-0.61%)
DIA : 418.05 (-0.56%)
$IUXX : 19,963.60 (-0.35%)
QQQ : 486.01 (-0.29%)
^BTCUSD : 67,865.18 (+1.22%)
ZNZ24 : 110-135 (+0.06%)
HUM : 255.55 (-1.98%)
CVS : 54.65 (-2.08%)
UNH : 557.77 (-1.72%)
CNC : 63.82 (+0.47%)
Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.47%. Stock indexes this...

$SPX : 5,712.69 (-0.28%)
SPY : 569.81 (-0.22%)
$DOWI : 41,794.60 (-0.61%)
DIA : 418.05 (-0.56%)
$IUXX : 19,963.60 (-0.35%)
QQQ : 486.01 (-0.29%)
ZNZ24 : 110-135 (+0.06%)
HUM : 255.55 (-1.98%)
CVS : 54.65 (-2.08%)
UNH : 557.77 (-1.72%)
ELV : 417.86 (+0.93%)
CNC : 63.82 (+0.47%)
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare

It's less scary to take on risky investments when the market is rising.

CRBU : 2.34 (+5.88%)
VERV : 6.05 (+2.02%)
Why Beam Therapeutics Stock Zoomed 17% Higher Today

JPMorgan Chase becomes the latest institution in the company's bull pen.

VERV : 6.05 (+2.02%)
LLY : 806.14 (-1.56%)
BEAM : 24.36 (+6.24%)
JPM : 219.78 (-1.42%)
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics

Curing rare inherited illnesses could be a lucrative business model.

CRSP : 50.59 (-0.33%)
NTLA : 15.14 (+2.23%)
VERV : 6.05 (+2.02%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 50.59 (-0.33%)
BEAM : 24.36 (+6.24%)
CRBU : 2.34 (+5.88%)
EDIT : 2.88 (-1.03%)
NTLA : 15.14 (+2.23%)
PRME : 3.96 (-1.74%)
VERV : 6.05 (+2.02%)
LLY : 806.14 (-1.56%)
REGN : 828.84 (-1.75%)
VRTX : 472.80 (+0.36%)
ARKG : 24.27 (+1.13%)
HOOD : 24.32 (+1.46%)

Barchart Exclusives

Is This High-Yield Dividend Stock a Buy After Earnings?
This pharmaceutical giant's Q3 numbers came in ahead of Street estimates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar